{
    "title": "Infrared Therapy",
    "inventor_name": "Gordon Dougal",
    "publication_year": 2008,
    "device_name": "Infrared Helmet",
    "goal": "To improve cognition and reverse symptoms of dementia/Alzheimer's by delivering near-infrared light to the brain.",
    "problem_addressed": "Cognitive decline and memory loss in dementia and Alzheimer's disease.",
    "concept_summary": "A wearable helmet containing ~700 near-infrared LEDs (~=1072 nm) that bathes the skull in low-power infrared light twice daily. The light is intended to stimulate cellular repair and neurogenesis, thereby slowing or reversing dementia symptoms.",
    "detailed_description": null,
    "category": "Medical & Dental Technologies",
    "principles": [
        "Photobiomodulation",
        "Near-infrared light stimulation of brain tissue"
    ],
    "scientific_domains": [
        "Medicine",
        "Neuroscience",
        "Photobiology"
    ],
    "mechanisms_of_action": [
        "Penetration of skull by 1072 nm light",
        "Stimulation of mitochondrial activity and cellular repair pathways",
        "Potential promotion of neurogenesis"
    ],
    "materials": [
        "Near-infrared LEDs",
        "Plastic/foam helmet housing"
    ],
    "energy_sources": [
        "Electrical power (LED driver)"
    ],
    "inputs": [
        "Electrical power supply",
        "Patient wearing helmet"
    ],
    "outputs": [
        "Low-power near-infrared light exposure to brain tissue"
    ],
    "claimed_performance": "Patients reported noticeable cognitive improvement within 10 days to 3 weeks; ability to hold conversations, shop, and perform daily tasks restored.",
    "experimental_evidence": "A single dementia patient (Clem Fennell) showed rapid improvement after 10-minute twice-daily sessions; researchers at University of Sunderland reported low-power 1072 nm light improved learning in independent studies.",
    "replication_status": "Prototype used on one patient; a 100-patient clinical trial is planned but not yet conducted.",
    "keywords": [
        "infrared therapy",
        "dementia",
        "Alzheimer's",
        "photobiomodulation",
        "LED helmet",
        "near-infrared"
    ],
    "related_technologies": [
        "Low-level laser therapy (LLLT)",
        "Photobiomodulation devices"
    ],
    "controversy_level": "medium",
    "confidence_score": 0.7,
    "practicability_score": 0.5,
    "fringe_score": 0.3,
    "evidence_strength": 0.4,
    "risk_score": 0.2,
    "trl_estimate": 3,
    "source_urls": [
        "http://www.mailonsunday.co.uk/health/article-1034936/Dementia-patient-makes-amazing-progress-using-infrared-helmet.html",
        "http://www.medicalnewstoday.com/articles/95334.php",
        "https://patents.google.com/patent/GB2415387",
        "https://patents.google.com/patent/EP1896131",
        "https://patents.google.com/patent/US2007129778"
    ],
    "organizations": [
        "Virulite",
        "University of Sunderland"
    ],
    "applications": [
        "Dementia treatment",
        "Alzheimer's disease therapy",
        "Cognitive enhancement"
    ],
    "limitations": [
        "Only anecdotal evidence; no peer-reviewed clinical data yet",
        "Effectiveness may vary between patients",
        "Unclear optimal dosage and treatment duration"
    ],
    "open_questions": [
        "What is the optimal wavelength, intensity, and exposure time?",
        "Are effects sustained long-term after treatment cessation?",
        "Can the technology be scaled safely for widespread clinical use?"
    ],
    "red_flags": [
        "Claims based on a single case report",
        "Lack of randomized controlled trials",
        "Potential for over-promising benefits"
    ],
    "evidence_quotes": [
        "\"Within ten days, the deterioration was stopped, then we started to see improvements\" - Mrs. Fennell",
        "\"He can now hold a conversation\" - Dr. Dougal",
        "\"Low power infra-red light (1072nm) improved learning\" - University of Sunderland researchers",
        "\"The treatment can indeed improve learning ability\" - Dr. Abdel Ennaceur",
        "\"A full, clinically controlled trial would be needed before his anti-dementia helmet could be licensed\" - Dr. Dougal"
    ]
}